COGNITION THERAPEUTICS INC (CGTX)
US19243B1026 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to CGTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.32. This target is 990.34% above the current price.
CGTX was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CGTX.
In the previous month the buy percentage consensus was at a similar level.
CGTX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-06 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2024-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-30 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-07-02 | Rodman & Renshaw | Reiterate | Buy -> Buy |
| 2024-06-06 | Chardan Capital | Initiate | Buy |
| 2024-05-29 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-28 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2024-03-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-14 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2023-05-09 | Oppenheimer | Reiterate | Outperform |
| 2023-03-24 | Oppenheimer | Reiterate | Outperform |
| 2022-09-29 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-04-22 | Ladenburg Thalmann | Initiate | Buy |
| 2021-11-03 | Oppenheimer | Initiate | Outperform |